GlassScriptPhysician profile
Richard Ohye
NPI 1720170111
$5,066.92
in general payments reported to CMS, 2019-2025
6 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,019 · 2023: $295 · 2024: $150 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,261 · Travel and Lodging: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,261.30 |
| Travel and Lodging | $286.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcym INC | $2,510.04 | 2025 | Haart, Memo 4d, Carbomedics Supra-Annular (Top Hat) |
| Artivion, INC. | $2,019.18 | 2019 | |
| Edwards Lifesciences Corporation | $153.74 | 2023 | Mitris Resilia Mitral Valve |
| Materialise USA LLC | $150.42 | 2024 | |
| Abiomed | $141.12 | 2023 | Impella |
| Becton, Dickinson and Company | $92.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ohye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.